Literature DB >> 7999104

Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor.

M Dougher-Vermazen1, J D Hulmes, P Böhlen, B I Terman.   

Abstract

Vascular endothelial growth factor (VEGF) is a potent angiogenic factor which binds to two structurally similar receptor tyrosine kinases, KDR and FLT1. Towards the goal of clarifying the signal transduction pathways by which VEGF activates endothelial cells, we expressed in bacteria an enzymatically active form of the cytosolic domain of the KDR receptor. The expressed protein undergoes autophosphorylation in both bacterial cells and in its purified form. Using peptide mapping and sequencing of peptides, we identified four tyrosine residues that are phosphorylated corresponding to residues 951, 996, 1054, and 1059 of the KDR protein. The location of the phosphorylated residues in the bacterially expressed protein, and/or the consensus sequences around these sites, suggest they may be identical to the phosphorylated sites of KDR in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999104     DOI: 10.1006/bbrc.1994.2726

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Evaluation of the angiogenesis inhibitor KR-31831 in SKOV-3 tumor-bearing mice using (64)Cu-DOTA-VEGF(121) and microPET.

Authors:  Iljung Lee; Kwang Yup Yoon; Choong Mo Kang; Xin Lin; Xiaoyuan Chen; Jung Young Kim; Sung-Min Kim; Eun Kyoung Ryu; Yearn Seong Choe
Journal:  Nucl Med Biol       Date:  2012-03-09       Impact factor: 2.408

2.  VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis.

Authors:  Taro Matsumoto; Svante Bohman; Johan Dixelius; Tone Berge; Anna Dimberg; Peetra Magnusson; Ling Wang; Charlotte Wikner; Jian Hua Qi; Christer Wernstedt; Jiong Wu; Skjalg Bruheim; Hideo Mugishima; Debrabata Mukhopadhyay; Anne Spurkland; Lena Claesson-Welsh
Journal:  EMBO J       Date:  2005-06-16       Impact factor: 11.598

Review 3.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 4.  Biological properties of VEGF/VPF receptors.

Authors:  B I Terman; M Dougher-Vermazen
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

5.  Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase.

Authors:  Shideh Kazerounian; Mark Duquette; Millys A Reyes; James T Lawler; Keli Song; Carole Perruzzi; Luca Primo; Roya Khosravi-Far; Federico Bussolino; Isaac Rabinovitz; Jack Lawler
Journal:  Blood       Date:  2011-03-04       Impact factor: 22.113

6.  Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells.

Authors:  Tom T Chen; Alfonso Luque; Sunyoung Lee; Sean M Anderson; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2010-02-22       Impact factor: 10.539

Review 7.  Cellular Based Strategies for Microvascular Engineering.

Authors:  Srinivas V Koduru; Ashley N Leberfinger; Denis Pasic; Anoosha Forghani; Shane Lince; Daniel J Hayes; Ibrahim T Ozbolat; Dino J Ravnic
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

8.  The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells.

Authors:  A J Warner; J Lopez-Dee; E L Knight; J R Feramisco; S A Prigent
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

9.  Expression of the vascular endothelial growth factor receptor, KDR, in human placenta.

Authors:  M Vuckovic; J Ponting; B I Terman; V Niketic; M W Seif; S Kumar
Journal:  J Anat       Date:  1996-04       Impact factor: 2.610

10.  Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells.

Authors:  Naveed Ahmed Khan; Francescopaolo Di Cello; Avi Nath; Kwang Sik Kim
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.